At a glance
- What the study gets you
- Access to the study treatment being tested
- Type of study
- Interventional (receives a drug or procedure)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- transcranial Direct Current Stimulation (device)
- How long the study runs
- Study runs about 21 months (dates as stated)
- About the drug or intervention
- transcranial Direct Current Stimulation — device: transcranial Direct Current Stimulation
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Testing a treatment
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 40
- Started
- 2024-12-01
- Last checked
- 2026-02
Plain English Summary
What is this study?
- • Testing a new treatment for tinnitus
- • NA - 40 participants
- • Tinnitus - the awareness of sound without any outside source - affects around 15% of people and can cause anxiety and depression
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with tinnitus
Where?
- • Nottingham - University of Nottingham
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Tinnitus - the awareness of sound without any outside source - affects around 15% of people and can cause anxiety and depression. Treatment options are limited and do not address tinnitus directly (e.g., reduce its loudness). To do that, we must change brain activity causing tinnitus. Low-dose electrical stimulation, using a technique called transcranial Direct Current Stimulation (tDCS), is a promising approach. The technique is safe and easy to administer. Several small studies have tested tDCS for tinnitus showing some benefits. To assess whether these benefits will generalise to other patients, we need to conduct a randomised controlled trial - a large, rigorously controlled experiment based on prior agreed procedures. Clinical trials are expensive and time-consuming to run and thus require meticulous pilot work to establish the most effective treatment regimens and the most sensitive measures of treatment outcome. The current study aims to provide such pilot information for a clinical trial of tDCS treatment of tinnitus. Using a total of 40 patients, we will establish how to best to administer tDCS and measure resulting changes in tinnitus perception and associated brain activity. The current study is a crucial first step towards determining whether or not tDCS can effectively treat tinnitus.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Aged 18 or over
- ✓Suffering from subjective idiopathic tinnitus
- ✓Sufficient understanding of English to be able to provide agreement to take part
- ✓Able to safely undergo tDCS
Who cannot take part
- ✗Aged under 18
- ✗Not suffering from tinnitus or suffering from objective tinnitus
- ✗Insufficient understanding of English to be able to provide agreement to take part
- ✗Unable to safely undergo tDCS as assessed by tDCS Safety Questionnaire
- ✗Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance
See the full criteria
Where Is This Study? (1 UK site)
University of Nottingham
Nottingham, United Kingdom
How to Get in Touch
Magdalena Sereda, PhD
Sponsor contactCONTACT